增长分化因子15通过AMP激活的蛋白激酶调解来保护糖尿病内皮功能障碍
Wen Zhao1, Yang Liu1, Zhengshuo Cui1
1The Key Laboratory of Remodeling Cardiovascular Diseases, Ministry of Education; Collaborative Innovation Center for Cardiovascular Disorders, Beijing Institute of Heart, Lung and Blood Vessel Disease, Beijing An Zhen Hospital, Capital Medical University, Beijing 100029, China.
Vascular pharmacology
|October 23, 2025
概括
增长分化因子15 (GDF15) 改善糖尿病内皮功能障碍并减少氧化应激. 这些益处通过内皮细胞中的AMP激活蛋白激酶 (AMPK) 途径进行介导,这表明GDF15是治疗点.
科学领域:
- 心血管研究研究心血管研究
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 内皮功能障碍是糖尿病并发症的关键因素.
- 驱动糖尿病内皮功能障碍的精确分子机制需要进一步阐明.
- 增长分化因子15 (GDF15) 与代谢和心血管疾病有关,但其在糖尿病内皮功能障碍中的作用尚不清楚.
研究的目的:
- 研究GDF15在减轻糖尿病内皮功能障碍方面的治疗潜力.
- 阐明GDF15对糖尿病患者内皮细胞的影响背后的分子机制.
主要方法:
- db/db和高葡萄糖/高脂质 (HG/HL) 治疗的小鼠大动脉用GDF15.15进行治疗.
- 使用线筋图进行了内皮依赖放松 (EDR) 的评估.
- 西方涂抹分析了NRF2,NOX2,ACE,ACE2和AMPK的蛋白质水平;通过共聚焦显微镜测量了反应性氧物种 (ROS) 的产生.
主要成果:
- 在糖尿病和HG/HL治疗的小鼠大动脉中,GDF15的使用显著改善了内皮功能障碍,并减少了ROS生成.
- GDF15治疗使NOX2,NRF2,ACE和ACE2在内皮细胞中的表达正常化.
- GDF15的保护作用与AMP激活蛋白激酶 (AMPK) 的上调有关,这是抑制研究证实的.
结论:
- GDF15有效地改善了糖尿病内皮功能障碍和氧化应激.
- 该机制涉及到内皮细胞内AMPK依赖途径的激活.
- 在糖尿病中,GDF15为控制氧化应激和保持内皮功能提供了一个有前途的治疗标.
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
01:16TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
01:22PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
01:25cAMP-dependent Protein Kinase Pathways
8.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.3K
01:22Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K